Global Specialty Active Pharmaceutical Ingredients Market Research Report 2020

Global Specialty Active Pharmaceutical Ingredients Market Research Report 2020

Table of Contents
1 Specialty Active Pharmaceutical Ingredients Market Overview
1.1 Product Overview and Scope of Specialty Active Pharmaceutical Ingredients
1.2 Specialty Active Pharmaceutical Ingredients Segment by Type
1.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Steroidal API
1.2.3 Peptide API
1.2.4 Carbohydrate API
1.2.5 Small Molecule API
1.2.6 High Potency AP
1.3 Specialty Active Pharmaceutical Ingredients Segment by Application
1.3.1 Specialty Active Pharmaceutical Ingredients Sales Comparison by Application: 2020 VS 2026
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Rheumatology
1.3.6 Diabetes
1.3.7 Oncology
1.3.8 Others
1.4 Global Specialty Active Pharmaceutical Ingredients Market Size Estimates and Forecasts
1.4.1 Global Specialty Active Pharmaceutical Ingredients Revenue 2015-2026
1.4.2 Global Specialty Active Pharmaceutical Ingredients Sales 2015-2026
1.4.3 Specialty Active Pharmaceutical Ingredients Market Size by Region: 2020 Versus 2026
1.5 Specialty Active Pharmaceutical Ingredients Industry
1.6 Specialty Active Pharmaceutical Ingredients Market Trends
2 Global Specialty Active Pharmaceutical Ingredients Market Competition by Manufacturers
2.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Manufacturers (2015-2020)
2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)
2.3 Global Specialty Active Pharmaceutical Ingredients Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Specialty Active Pharmaceutical Ingredients Manufacturing Sites, Area Served, Product Type
2.5 Specialty Active Pharmaceutical Ingredients Market Competitive Situation and Trends
2.5.1 Specialty Active Pharmaceutical Ingredients Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Specialty Active Pharmaceutical Ingredients Players (Opinion Leaders)
3 Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario by Region
3.1 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Country
3.3.1 North America Specialty Active Pharmaceutical Ingredients Sales by Country
3.3.2 North America Specialty Active Pharmaceutical Ingredients Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Country
3.4.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Country
3.4.2 Europe Specialty Active Pharmaceutical Ingredients Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Region
3.5.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region
3.5.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Country
3.6.1 Latin America Specialty Active Pharmaceutical Ingredients Sales by Country
3.6.2 Latin America Specialty Active Pharmaceutical Ingredients Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Country
3.7.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country
3.7.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Specialty Active Pharmaceutical Ingredients Historic Market Analysis by Type
4.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
4.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2015-2020)
4.3 Global Specialty Active Pharmaceutical Ingredients Price Market Share by Type (2015-2020)
4.4 Global Specialty Active Pharmaceutical Ingredients Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Specialty Active Pharmaceutical Ingredients Historic Market Analysis by Application
5.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
5.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2015-2020)
5.3 Global Specialty Active Pharmaceutical Ingredients Price by Application (2015-2020)
6 Company Profiles and Key Figures in Specialty Active Pharmaceutical Ingredients Business
6.1 Sanofi
6.1.1 Corporation Information
6.1.2 Sanofi Description, Business Overview and Total Revenue
6.1.3 Sanofi Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Sanofi Products Offered
6.1.5 Sanofi Recent Development
6.2 Cambrex
6.2.1 Cambrex Corporation Information
6.2.2 Cambrex Description, Business Overview and Total Revenue
6.2.3 Cambrex Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Cambrex Products Offered
6.2.5 Cambrex Recent Development
6.3 Almac
6.3.1 Almac Corporation Information
6.3.2 Almac Description, Business Overview and Total Revenue
6.3.3 Almac Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Almac Products Offered
6.3.5 Almac Recent Development
6.4 Johnson Matthey
6.4.1 Johnson Matthey Corporation Information
6.4.2 Johnson Matthey Description, Business Overview and Total Revenue
6.4.3 Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Johnson Matthey Products Offered
6.4.5 Johnson Matthey Recent Development
6.5 PolyPeptide
6.5.1 PolyPeptide Corporation Information
6.5.2 PolyPeptide Description, Business Overview and Total Revenue
6.5.3 PolyPeptide Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
6.5.4 PolyPeptide Products Offered
6.5.5 PolyPeptide Recent Development
6.6 AmbioPharm
6.6.1 AmbioPharm Corporation Information
6.6.2 AmbioPharm Description, Business Overview and Total Revenue
6.6.3 AmbioPharm Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
6.6.4 AmbioPharm Products Offered
6.6.5 AmbioPharm Recent Development
6.7 Avecia
6.6.1 Avecia Corporation Information
6.6.2 Avecia Description, Business Overview and Total Revenue
6.6.3 Avecia Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Avecia Products Offered
6.7.5 Avecia Recent Development
6.8 ST Pharm
6.8.1 ST Pharm Corporation Information
6.8.2 ST Pharm Description, Business Overview and Total Revenue
6.8.3 ST Pharm Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
6.8.4 ST Pharm Products Offered
6.8.5 ST Pharm Recent Development
6.9 Biospring
6.9.1 Biospring Corporation Information
6.9.2 Biospring Description, Business Overview and Total Revenue
6.9.3 Biospring Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Biospring Products Offered
6.9.5 Biospring Recent Development
7 Specialty Active Pharmaceutical Ingredients Manufacturing Cost Analysis
7.1 Specialty Active Pharmaceutical Ingredients Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Specialty Active Pharmaceutical Ingredients
7.4 Specialty Active Pharmaceutical Ingredients Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Specialty Active Pharmaceutical Ingredients Distributors List
8.3 Specialty Active Pharmaceutical Ingredients Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Specialty Active Pharmaceutical Ingredients Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Specialty Active Pharmaceutical Ingredients by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Specialty Active Pharmaceutical Ingredients by Type (2021-2026)
10.2 Specialty Active Pharmaceutical Ingredients Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Specialty Active Pharmaceutical Ingredients by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Specialty Active Pharmaceutical Ingredients by Application (2021-2026)
10.3 Specialty Active Pharmaceutical Ingredients Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Specialty Active Pharmaceutical Ingredients by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Specialty Active Pharmaceutical Ingredients by Region (2021-2026)
10.4 North America Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)
10.5 Europe Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)
10.6 Asia Pacific Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)
10.7 Latin America Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)
10.8 Middle East and Africa Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Specialty Active Pharmaceutical Ingredients Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Specialty Active Pharmaceutical Ingredients Manufacturers Covered in This Study
Table 5. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturers (2015-2020)
Table 7. Global Specialty Active Pharmaceutical Ingredients Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Specialty Active Pharmaceutical Ingredients Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Specialty Active Pharmaceutical Ingredients Sales Sites and Area Served
Table 11. Manufacturers Specialty Active Pharmaceutical Ingredients Product Types
Table 12. Global Specialty Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Specialty Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Active Pharmaceutical Ingredients as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Specialty Active Pharmaceutical Ingredients Players
Table 16. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Region (2015-2020)
Table 17. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)
Table 18. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) by Region (2015-2020)
Table 19. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)
Table 20. North America Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 21. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 22. North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 24. Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 25. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 26. Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)
Table 32. Latin America Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 33. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 34. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 40. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Type (2015-2020)
Table 41. Global Specialty Active Pharmaceutical Ingredients Sales Share by Type (2015-2020)
Table 42. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) by Type (2015-2020)
Table 43. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Type (2015-2020)
Table 44. Global Specialty Active Pharmaceutical Ingredients Price (USD/MT) by Type (2015-2020)
Table 45. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Application (2015-2020)
Table 46. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 47. Global Specialty Active Pharmaceutical Ingredients Sales Growth Rate by Application (2015-2020)
Table 48. Sanofi Specialty Active Pharmaceutical Ingredients Corporation Information
Table 49. Sanofi Description and Business Overview
Table 50. Sanofi Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Sanofi Main Product
Table 52. Sanofi Recent Development
Table 53. Cambrex Specialty Active Pharmaceutical Ingredients Corporation Information
Table 54. Cambrex Corporation Information
Table 55. Cambrex Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Cambrex Main Product
Table 57. Cambrex Recent Development
Table 58. Almac Specialty Active Pharmaceutical Ingredients Corporation Information
Table 59. Almac Corporation Information
Table 60. Almac Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Almac Main Product
Table 62. Almac Recent Development
Table 63. Johnson Matthey Specialty Active Pharmaceutical Ingredients Corporation Information
Table 64. Johnson Matthey Corporation Information
Table 65. Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Johnson Matthey Main Product
Table 67. Johnson Matthey Recent Development
Table 68. PolyPeptide Specialty Active Pharmaceutical Ingredients Corporation Information
Table 69. PolyPeptide Corporation Information
Table 70. PolyPeptide Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. PolyPeptide Main Product
Table 72. PolyPeptide Recent Development
Table 73. AmbioPharm Specialty Active Pharmaceutical Ingredients Corporation Information
Table 74. AmbioPharm Corporation Information
Table 75. AmbioPharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. AmbioPharm Main Product
Table 77. AmbioPharm Recent Development
Table 78. Avecia Specialty Active Pharmaceutical Ingredients Corporation Information
Table 79. Avecia Corporation Information
Table 80. Avecia Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Avecia Main Product
Table 82. Avecia Recent Development
Table 83. ST Pharm Specialty Active Pharmaceutical Ingredients Corporation Information
Table 84. ST Pharm Corporation Information
Table 85. ST Pharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. ST Pharm Main Product
Table 87. ST Pharm Recent Development
Table 88. Biospring Specialty Active Pharmaceutical Ingredients Corporation Information
Table 89. Biospring Corporation Information
Table 90. Biospring Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Biospring Main Product
Table 92. Biospring Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Specialty Active Pharmaceutical Ingredients Distributors List
Table 96. Specialty Active Pharmaceutical Ingredients Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Forecast by Type (2021-2026)
Table 101. Global Specialty Active Pharmaceutical Ingredients Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Forecast by Application (2021-2026)
Table 105. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Forecast by Region (2021-2026)
Table 107. Global Specialty Active Pharmaceutical Ingredients Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Specialty Active Pharmaceutical Ingredients
Figure 2. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type: 2020 VS 2026
Figure 3. Steroidal API Product Picture
Figure 4. Peptide API Product Picture
Figure 5. Carbohydrate API Product Picture
Figure 6. Small Molecule API Product Picture
Figure 7. High Potency AP Product Picture
Figure 8. Global Specialty Active Pharmaceutical Ingredients Consumption Market Share by Application: 2020 VS 2026
Figure 9. CNS
Figure 10. Cardiovascular
Figure 11. Genitourinary/Hormonal Drugs
Figure 12. Rheumatology
Figure 13. Diabetes
Figure 14. Oncology
Figure 15. Others
Figure 16. Global Specialty Active Pharmaceutical Ingredients Market Size 2015-2026 (US$ Million)
Figure 17. Global Specialty Active Pharmaceutical Ingredients Sales Capacity (K MT) (2015-2026)
Figure 18. Global Specialty Active Pharmaceutical Ingredients Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturers in 2020
Figure 20. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers in 2019
Figure 21. The Global 5 and 10 Largest Players: Market Share by Specialty Active Pharmaceutical Ingredients Revenue in 2019
Figure 22. Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)
Figure 24. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region in 2019
Figure 25. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)
Figure 26. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region in 2019
Figure 27. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 28. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 29. U.S. Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 30. U.S. Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. Canada Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 32. Canada Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 34. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 35. Germany Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 36. Germany Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. France Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 38. France Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. U.K. Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 40. U.K. Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Italy Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 42. Italy Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Russia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 44. Russia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Region in 2019
Figure 46. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region in 2019
Figure 47. China Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 48. China Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Japan Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 50. Japan Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. South Korea Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 52. South Korea Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. India Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 54. India Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Australia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 56. Australia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Taiwan Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 58. Taiwan Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Indonesia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 60. Indonesia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Thailand Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 62. Thailand Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Malaysia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 64. Malaysia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Philippines Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 66. Philippines Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Vietnam Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 68. Vietnam Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 70. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 71. Mexico Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 72. Mexico Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Brazil Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 74. Brazil Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Argentina Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 76. Argentina Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 78. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 79. Turkey Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Saudi Arabia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 82. Saudi Arabia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. U.A.E Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 84. U.A.E Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Sales Market Share of Specialty Active Pharmaceutical Ingredients by Type (2015-2020)
Figure 86. Sales Market Share of Specialty Active Pharmaceutical Ingredients by Type in 2019
Figure 87. Revenue Share of Specialty Active Pharmaceutical Ingredients by Type (2015-2020)
Figure 88. Revenue Market Share of Specialty Active Pharmaceutical Ingredients by Type in 2019
Figure 89. Global Specialty Active Pharmaceutical Ingredients Sales Growth by Type (2015-2020) (K MT)
Figure 90. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Figure 91. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application in 2019
Figure 92. Global Revenue Share of Specialty Active Pharmaceutical Ingredients by Application (2015-2020)
Figure 93. Global Revenue Share of Specialty Active Pharmaceutical Ingredients by Application in 2020
Figure 94. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Cambrex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Almac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Johnson Matthey Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. PolyPeptide Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. AmbioPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Avecia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. ST Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Biospring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Price Trend of Key Raw Materials
Figure 104. Manufacturing Cost Structure of Specialty Active Pharmaceutical Ingredients
Figure 105. Manufacturing Process Analysis of Specialty Active Pharmaceutical Ingredients
Figure 106. Specialty Active Pharmaceutical Ingredients Industrial Chain Analysis
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Porter's Five Forces Analysis
Figure 110. North America Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 111. North America Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Europe Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 113. Europe Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Latin America Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 115. Latin America Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 117. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 119. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs